U.S. Markets close in 5 hrs 26 mins

Mustang Bio, Inc. (MBIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.8490+0.0490 (+1.75%)
As of 10:34AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.8000
Open2.8000
Bid2.8700 x 4000
Ask2.8800 x 3100
Day's Range2.7800 - 2.8800
52 Week Range2.4200 - 5.2200
Volume298,368
Avg. Volume1,722,065
Market Cap248.756M
Beta (5Y Monthly)1.72
PE Ratio (TTM)N/A
EPS (TTM)-1.0150
Earnings DateMar 24, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est10.40
  • 15 Best Penny Stocks to Buy Now
    Insider Monkey

    15 Best Penny Stocks to Buy Now

    In this article, we discuss the 15 best penny stocks to buy now. If you want to skip our detailed analysis of these companies, go directly to the 5 Best Penny Stocks to Buy Now. Many novice investors are bullish on penny stocks with growth potential for capital appreciation. All iconic stocks were once penny […]

  • Mustang Bio Awarded Massachusetts Life Sciences Center Tax Incentive
    GlobeNewswire

    Mustang Bio Awarded Massachusetts Life Sciences Center Tax Incentive

    WORCESTER, Mass., June 17, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that it was one of 28 recipients awarded tax incentives from the Massachusetts Life Sciences Center (“MLSC”). The $300,000 tax incentive amount that Mustang was awarded is based

  • Mustang Bio to Present at the Raymond James Human Health Innovation Conference
    GlobeNewswire

    Mustang Bio to Present at the Raymond James Human Health Innovation Conference

    WORCESTER, Mass., June 16, 2021 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that Manuel Litchman, M.D., President and Chief Executive Officer, will present at the Raymond James Human Health Innovation Conference, taking place virtually from June 21 - 23